336 related articles for article (PubMed ID: 16451048)
1. Aminoethylenes: a tetrahedral intermediate isostere yielding potent inhibitors of the aspartyl protease BACE-1.
Yang W; Lu W; Lu Y; Zhong M; Sun J; Thomas AE; Wilkinson JM; Fucini RV; Lam M; Randal M; Shi XP; Jacobs JW; McDowell RS; Gordon EM; Ballinger MD
J Med Chem; 2006 Feb; 49(3):839-42. PubMed ID: 16451048
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of potent BACE-1 inhibitors incorporating a hydroxyethylene isostere as central core.
Wångsell F; Gustafsson K; Kvarnström I; Borkakoti N; Edlund M; Jansson K; Lindberg J; Hallberg A; Rosenquist A; Samuelsson B
Eur J Med Chem; 2010 Mar; 45(3):870-82. PubMed ID: 20036448
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, SAR, and X-ray structure of human BACE-1 inhibitors with cyclic urea derivatives.
Park H; Min K; Kwak HS; Koo KD; Lim D; Seo SW; Choi JU; Platt B; Choi DY
Bioorg Med Chem Lett; 2008 May; 18(9):2900-4. PubMed ID: 18434152
[TBL] [Abstract][Full Text] [Related]
4. Discovery of potent BACE-1 inhibitors containing a new hydroxyethylene (HE) scaffold: exploration of P1' alkoxy residues and an aminoethylene (AE) central core.
Björklund C; Adolfsson H; Jansson K; Lindberg J; Vrang L; Hallberg A; Rosenquist S; Samuelsson B
Bioorg Med Chem; 2010 Feb; 18(4):1711-23. PubMed ID: 20122837
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of hydroxyethylene-based peptidomimetic inhibitors of human beta-secretase.
Hom RK; Gailunas AF; Mamo S; Fang LY; Tung JS; Walker DE; Davis D; Thorsett ED; Jewett NE; Moon JB; John V
J Med Chem; 2004 Jan; 47(1):158-64. PubMed ID: 14695829
[TBL] [Abstract][Full Text] [Related]
6. Structure-based design of potent and selective cell-permeable inhibitors of human beta-secretase (BACE-1).
Stachel SJ; Coburn CA; Steele TG; Jones KG; Loutzenhiser EF; Gregro AR; Rajapakse HA; Lai MT; Crouthamel MC; Xu M; Tugusheva K; Lineberger JE; Pietrak BL; Espeseth AS; Shi XP; Chen-Dodson E; Holloway MK; Munshi S; Simon AJ; Kuo L; Vacca JP
J Med Chem; 2004 Dec; 47(26):6447-50. PubMed ID: 15588077
[TBL] [Abstract][Full Text] [Related]
7. Preorganization of the hydroxyethylene dipeptide isostere: the preferred conformation in solution resembles the conformation bound to BACE.
Vidal P; Timm D; Broughton H; Chen SH; Martín JA; Rivera-Sagredo A; McCarthy JR; Shapiro MJ; Espinosa JF
J Med Chem; 2005 Dec; 48(24):7623-7. PubMed ID: 16302802
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of hydroxyethylamine (HEA) BACE-1 inhibitors: structure-activity relationship of the aryl region.
Probst GD; Bowers S; Sealy JM; Stupi B; Dressen D; Jagodzinska BM; Aquino J; Gailunas A; Truong AP; Tso L; Xu YZ; Hom RK; John V; Tung JS; Pleiss MA; Tucker JA; Konradi AW; Sham HL; Jagodzinski J; Toth G; Brecht E; Yao N; Pan H; Lin M; Artis DR; Ruslim L; Bova MP; Sinha S; Yednock TA; Gauby S; Zmolek W; Quinn KP; Sauer JM
Bioorg Med Chem Lett; 2010 Oct; 20(20):6034-9. PubMed ID: 20822903
[TBL] [Abstract][Full Text] [Related]
9. BACE-1 inhibition by a series of psi[CH2NH] reduced amide isosteres.
Coburn CA; Stachel SJ; Jones KG; Steele TG; Rush DM; DiMuzio J; Pietrak BL; Lai MT; Huang Q; Lineberger J; Jin L; Munshi S; Katharine Holloway M; Espeseth A; Simon A; Hazuda D; Graham SL; Vacca JP
Bioorg Med Chem Lett; 2006 Jul; 16(14):3635-8. PubMed ID: 16690314
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and evaluation of Leu*Ala hydroxyethylene-based non-peptide beta-secretase (BACE) inhibitors.
Xiao K; Li X; Li J; Ma L; Hu B; Yu H; Fu Y; Wang R; Ma Z; Qiu B; Li J; Hu D; Wang X; Shen J
Bioorg Med Chem; 2006 Jul; 14(13):4535-51. PubMed ID: 16510290
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and SAR of potent statine-based BACE-1 inhibitors: exploration of P1 phenoxy and benzyloxy residues.
Bäck M; Nyhlén J; Kvarnström I; Appelgren S; Borkakoti N; Jansson K; Lindberg J; Nyström S; Hallberg A; Rosenquist S; Samuelsson B
Bioorg Med Chem; 2008 Nov; 16(21):9471-86. PubMed ID: 18842420
[TBL] [Abstract][Full Text] [Related]
12. Highly potent macrocyclic BACE-1 inhibitors incorporating a hydroxyethylamine core: design, synthesis and X-ray crystal structures of enzyme inhibitor complexes.
Sandgren V; Agback T; Johansson PO; Lindberg J; Kvarnström I; Samuelsson B; Belda O; Dahlgren A
Bioorg Med Chem; 2012 Jul; 20(14):4377-89. PubMed ID: 22698785
[TBL] [Abstract][Full Text] [Related]
13. P2'-truncated BACE-1 inhibitors with a novel hydroxethylene-like core.
Meredith JA; Björklund C; Adolfsson H; Jansson K; Hallberg A; Rosenquist A; Samuelsson B
Eur J Med Chem; 2010 Feb; 45(2):542-54. PubMed ID: 19995674
[TBL] [Abstract][Full Text] [Related]
14. Structure-based design and synthesis of macrocyclic peptidomimetic beta-secretase (BACE-1) inhibitors.
Machauer R; Veenstra S; Rondeau JM; Tintelnot-Blomley M; Betschart C; Neumann U; Paganetti P
Bioorg Med Chem Lett; 2009 Mar; 19(5):1361-5. PubMed ID: 19195886
[TBL] [Abstract][Full Text] [Related]
15. Determination of the active site protonation state of beta-secretase from molecular dynamics simulation and docking experiment: implications for structure-based inhibitor design.
Park H; Lee S
J Am Chem Soc; 2003 Dec; 125(52):16416-22. PubMed ID: 14692784
[TBL] [Abstract][Full Text] [Related]
16. BACE-1 inhibitors part 1: identification of novel hydroxy ethylamines (HEAs).
Clarke B; Demont E; Dingwall C; Dunsdon R; Faller A; Hawkins J; Hussain I; MacPherson D; Maile G; Matico R; Milner P; Mosley J; Naylor A; O'Brien A; Redshaw S; Riddell D; Rowland P; Soleil V; Smith KJ; Stanway S; Stemp G; Sweitzer S; Theobald P; Vesey D; Walter DS; Ward J; Wayne G
Bioorg Med Chem Lett; 2008 Feb; 18(3):1011-6. PubMed ID: 18171614
[TBL] [Abstract][Full Text] [Related]
17. Second generation of BACE-1 inhibitors part 2: Optimisation of the non-prime side substituent.
Charrier N; Clarke B; Demont E; Dingwall C; Dunsdon R; Hawkins J; Hubbard J; Hussain I; Maile G; Matico R; Mosley J; Naylor A; O'Brien A; Redshaw S; Rowland P; Soleil V; Smith KJ; Sweitzer S; Theobald P; Vesey D; Walter DS; Wayne G
Bioorg Med Chem Lett; 2009 Jul; 19(13):3669-73. PubMed ID: 19477642
[TBL] [Abstract][Full Text] [Related]
18. Improving the permeability of the hydroxyethylamine BACE-1 inhibitors: structure-activity relationship of P2' substituents.
Truong AP; Probst GD; Aquino J; Fang L; Brogley L; Sealy JM; Hom RK; Tucker JA; John V; Tung JS; Pleiss MA; Konradi AW; Sham HL; Dappen MS; Tóth G; Yao N; Brecht E; Pan H; Artis DR; Ruslim L; Bova MP; Sinha S; Yednock TA; Zmolek W; Quinn KP; Sauer JM
Bioorg Med Chem Lett; 2010 Aug; 20(16):4789-94. PubMed ID: 20634069
[TBL] [Abstract][Full Text] [Related]
19. Potent pyrrolidine- and piperidine-based BACE-1 inhibitors.
Iserloh U; Wu Y; Cumming JN; Pan J; Wang LY; Stamford AW; Kennedy ME; Kuvelkar R; Chen X; Parker EM; Strickland C; Voigt J
Bioorg Med Chem Lett; 2008 Jan; 18(1):414-7. PubMed ID: 18023580
[TBL] [Abstract][Full Text] [Related]
20. Naphthyl and coumarinyl biarylpiperazine derivatives as highly potent human beta-secretase inhibitors. Design, synthesis, and enzymatic BACE-1 and cell assays.
Garino C; Tomita T; Pietrancosta N; Laras Y; Rosas R; Herbette G; Maigret B; Quéléver G; Iwatsubo T; Kraus JL
J Med Chem; 2006 Jul; 49(14):4275-85. PubMed ID: 16821787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
